Former Teva CEO Eli Hurvitz dies of cancer at 79

Ex-CEO of leading generics company and Israel Prize winner succumbs to cancer.

Eli Hurvitz 311 (photo credit: Wikimedia Commons)
Eli Hurvitz 311
(photo credit: Wikimedia Commons)
Teva pharmaceuticals former CEO Eli Hurvitz died of cancer at the age of 79 Monday night at Sheba Hospital in Tel Hashomer.
Having served as the company's CEO and chairman, Hurvitz retired for medical reasons in 2009.
RELATED:Teva to set up Israeli drug development VC fund Teva to power factory with natural gas
President Shimon Peres, who heard of Hurvitz's death while on route to Vietnam, said "his loss is a personal loss to me and an even greater loss to the State of Israel." He went on to call Hurvitz a "unique human being" and an unpretentious, modest individual, who through Teva had contributed to the saving of millions of lives.
After learning of his death, Prime Minister Binyamin Netanyahu said of Hurvitz: "He was among the great manufacturers to arise in the state of Israel."
"There was no better ambassador for Israeli entrepreneurship and spirit," Netanyahu concluded.
Finance Minister Yuval Steinitz added that Hurvitz turned a small company into a global giant, calling him a visionary in every sense of the word.
Hurvitz won the Israel Prize in 2002 for his contributions to the state.
Teva is the largest generic drug manufacturer in the world, and the 15th largest company listed on the NASDAQ.